Whittier Trust Co. Increases Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

Whittier Trust Co. increased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 1.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,940 shares of the medical research company's stock after purchasing an additional 1,351 shares during the period. Whittier Trust Co.'s holdings in Thermo Fisher Scientific were worth $44,255,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Bernard Wealth Management Corp. purchased a new position in shares of Thermo Fisher Scientific during the fourth quarter worth $25,000. Ameriflex Group Inc. purchased a new position in shares of Thermo Fisher Scientific during the fourth quarter worth $30,000. Cassady Schiller Wealth Management LLC grew its position in Thermo Fisher Scientific by 89.2% during the fourth quarter. Cassady Schiller Wealth Management LLC now owns 70 shares of the medical research company's stock valued at $36,000 after buying an additional 33 shares during the period. VSM Wealth Advisory LLC acquired a new stake in Thermo Fisher Scientific during the fourth quarter valued at $36,000. Finally, Navigoe LLC acquired a new stake in Thermo Fisher Scientific during the fourth quarter valued at $37,000. Hedge funds and other institutional investors own 89.23% of the company's stock.

Analyst Ratings Changes

TMO has been the topic of several analyst reports. The Goldman Sachs Group set a $610.00 price target on shares of Thermo Fisher Scientific and gave the company a "buy" rating in a research report on Wednesday, April 23rd. Evercore ISI dropped their price target on shares of Thermo Fisher Scientific from $500.00 to $480.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Stifel Nicolaus dropped their price target on shares of Thermo Fisher Scientific from $665.00 to $620.00 and set a "buy" rating on the stock in a research report on Thursday, April 24th. Robert W. Baird reduced their price target on shares of Thermo Fisher Scientific from $573.00 to $553.00 and set an "outperform" rating for the company in a research report on Friday. Finally, Barclays decreased their price target on shares of Thermo Fisher Scientific from $475.00 to $450.00 and set an "equal weight" rating on the stock in a research note on Tuesday, June 24th. Four research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. Based on data from MarketBeat, Thermo Fisher Scientific presently has a consensus rating of "Moderate Buy" and an average price target of $599.30.

Thermo Fisher Scientific Price Performance

TMO traded down $13.24 on Friday, reaching $411.74. 1,520,718 shares of the company's stock were exchanged, compared to its average volume of 2,016,365. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.77 and a quick ratio of 1.38. The stock has a market cap of $155.43 billion, a PE ratio of 24.15, a P/E/G ratio of 2.21 and a beta of 0.77. The stock's fifty day moving average price is $410.13 and its 200-day moving average price is $473.73. Thermo Fisher Scientific Inc. has a twelve month low of $385.46 and a twelve month high of $627.88.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The medical research company reported $5.15 earnings per share for the quarter, beating the consensus estimate of $5.10 by $0.05. The company had revenue of $10.36 billion for the quarter, compared to analyst estimates of $10.23 billion. Thermo Fisher Scientific had a net margin of 15.19% and a return on equity of 17.15%. Thermo Fisher Scientific's revenue was up .2% on a year-over-year basis. During the same period in the previous year, the business posted $5.11 EPS. Sell-side analysts expect that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.

Thermo Fisher Scientific Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Monday, September 15th will be issued a $0.43 dividend. The ex-dividend date is Monday, September 15th. This represents a $1.72 annualized dividend and a yield of 0.42%. Thermo Fisher Scientific's payout ratio is 10.09%.

Insiders Place Their Bets

In other news, EVP Gianluca Pettiti sold 300 shares of the company's stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $429.93, for a total value of $128,979.00. Following the transaction, the executive vice president directly owned 23,167 shares in the company, valued at approximately $9,960,188.31. This represents a 1.28% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is owned by insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.